Encompass Health Corporation $EHC Stock: Inspire Investing LLC Raises Stake

Inspire Investing LLC raised its position in Encompass Health Corporation (NYSE:EHC) by 66.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 65,010 shares of the company’s stock after purchasing an additional 25,878 shares during the quarter. Inspire Investing LLC owned 0.07% of Encompass Health worth $7,898,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in EHC. Root Financial Partners LLC purchased a new stake in shares of Encompass Health in the third quarter worth approximately $52,000. Quadrant Capital Group LLC boosted its holdings in Encompass Health by 25.0% during the 3rd quarter. Quadrant Capital Group LLC now owns 11,602 shares of the company’s stock valued at $1,442,000 after acquiring an additional 2,318 shares during the period. Nisa Investment Advisors LLC boosted its holdings in Encompass Health by 3.1% during the 3rd quarter. Nisa Investment Advisors LLC now owns 17,501 shares of the company’s stock valued at $2,126,000 after acquiring an additional 519 shares during the period. Diversify Advisory Services LLC grew its position in Encompass Health by 94.6% in the 3rd quarter. Diversify Advisory Services LLC now owns 10,758 shares of the company’s stock valued at $1,374,000 after acquiring an additional 5,231 shares during the last quarter. Finally, Fort Washington Investment Advisors Inc. OH grew its position in Encompass Health by 19.8% in the 3rd quarter. Fort Washington Investment Advisors Inc. OH now owns 281,075 shares of the company’s stock valued at $34,148,000 after acquiring an additional 46,512 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Insider Activity at Encompass Health

In related news, EVP John Darby sold 4,858 shares of Encompass Health stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $121.09, for a total value of $588,255.22. Following the completion of the sale, the executive vice president owned 75,041 shares in the company, valued at approximately $9,086,714.69. This trade represents a 6.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Mark Tarr sold 173,148 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $125.47, for a total value of $21,724,879.56. Following the completion of the sale, the chief executive officer directly owned 267,814 shares in the company, valued at approximately $33,602,622.58. The trade was a 39.27% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 186,912 shares of company stock valued at $23,434,845 in the last quarter. 1.80% of the stock is owned by insiders.

Encompass Health Stock Down 1.4%

Shares of NYSE:EHC opened at $124.23 on Friday. The stock has a market cap of $12.26 billion, a P/E ratio of 20.23, a price-to-earnings-growth ratio of 2.55 and a beta of 0.74. Encompass Health Corporation has a 52-week low of $92.77 and a 52-week high of $129.96. The business’s 50 day moving average is $122.35 and its 200 day moving average is $112.46. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.48 by $0.07. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The company had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.57 billion. During the same quarter last year, the firm posted $1.40 earnings per share. Encompass Health’s revenue was up 9.6% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Sell-side analysts predict that Encompass Health Corporation will post 6.08 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 15th. Investors of record on Monday, January 4th will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Monday, January 4th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is presently 13.68%.

Analysts Set New Price Targets

Several analysts have recently weighed in on EHC shares. Wall Street Zen downgraded Encompass Health from a “buy” rating to a “hold” rating in a research report on Saturday, October 17th. UBS Group boosted their target price on shares of Encompass Health from $150.00 to $155.00 and gave the company a “buy” rating in a research note on Friday, August 7th. TD Cowen raised their price target on shares of Encompass Health from $125.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, August 10th. Weiss Ratings raised shares of Encompass Health from a “buy (b-)” rating to a “buy (b)” rating in a research note on Thursday, October 8th. Finally, Truist Financial lifted their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a report on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, Encompass Health currently has an average rating of “Buy” and a consensus price target of $148.50.

Encompass Health Profile

Encompass Health Corporation (NYSE:EHC) is a healthcare services company that operates inpatient rehabilitation hospitals in the United States and Puerto Rico. Its hospitals provide intensive rehabilitation to patients recovering from conditions such as stroke, brain and spinal cord injuries, neurological disorders, amputations, hip fractures and other serious illnesses or injuries.

The company’s services typically include nursing care, physical therapy, occupational therapy, speech and language therapy, respiratory therapy and medical management.